Found 8 matching trials
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD PHASE4 This 4-week study will evaluate the safety and efficacy of crisaborole oint...
Show More Location
Dermatology Trial Associates
Learn More & Join Trial
Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis PHASE3 A phase 3, double-blind, randomized, parallel-group, placebo-controlled, mu...
Show More Location
Multiple Locations
Learn More & Join Trial
A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis PHASE2 This is an exploratory study to determine effectiveness of Elidel for the t...
Show More Location
Dermatology Specialists
Learn More & Join Trial
Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease PHASE2 The development of the topical calcineurin inhibitor pimecrolimus resulted ...
Show More Location
Department of Dermtology, University of Münster
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients PHASE1 This study aims to evaluate the safety, tolerability and pharmacokinetic pr...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children PHASE4 Primecrolimus cream 1% is effective in the treatment of atopic dermatitis i...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis PHASE3 The purpose of this study is to compare the safety and efficacy profiles of...
Show More Location
Pinnacle Research Group, LLC
Learn More & Join Trial
A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis PHASE1 The purpose of this study is to validate a left-right design with respect t...
Show More Learn More & Join Trial